Iria Vazquez (Iria Vázquez)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

Cancers

Journal of clinical medicine

Blood advances

Universidad de Navarra

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Navarra

Spain

PhD :: CIMA LAB Diagnostics

Publications

Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Paula Aguirre-Ruiz, Beñat Ariceta, María Cruz Viguria, María Teresa Zudaire, Zuriñe Blasco-Iturri, Patricia Arnedo, Almudena Aguilera-Diaz, Axier Jauregui, Amagoia Mañú, Felipe Prosper, María Carmen Mateos, Marta Fernández-Mercado, María José Larráyoz, Margarita Redondo, María-José Calasanz, Iria Vazquez, Eva Bandres
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. Journal of clinical medicine 9 (12) (2020)

Iria Vazquez.css-eqlu8i{font-size:small;padding-left:4px;} (Iria Vázquez)

Publication Activity (10 Years)

Top Topics

Top Venues

Iria Vazquez (Iria Vázquez)